Ruth Demeersseman is a Clinical Trial Coordinator in Hematology at AZ Delta since October 2016, following a role as a Research Associate at Ablynx from October 2015 to September 2016. Ruth holds a Master's degree in Management en beleid in de gezondheidszorg from KU Leuven, completed in June 2020, as well as a Master's degree in Biochemistry and Biotechnology earned in 2015 and a Bachelor's degree in the same field obtained in 2013 from KU Leuven. Educational background includes completion of secondary education at Vrije Middelbare School from 2004 to 2010.